Aditxt

Aditxt DSCR

The Debt Service Coverage Ratio (DSCR) of Aditxt (ADTX) as of Oct 27, 2026 is -8,544.19. In the previous year, Debt Service Coverage Ratio (DSCR) was -2.42 — a change of 352,654.58% (lower).

DSCR

-8,544.19

YoY

352,654.58%

Last updated:

Debt Service Coverage Ratio (DSCR) of Aditxt is 2025 -8,544.19 . Debt Service Coverage Ratio (DSCR) of Aditxt was 2024 -2.42 . It decreases by 352,654.58% lower compared to the previous year.

The Aditxt DSCR history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

DSCR
Date
DSCR
Jan 1, 2018
-2.36 USD
Jan 1, 2019
-2.80 USD
Jan 1, 2020
-3.93 USD
Jan 1, 2021
-4.72 USD
Jan 1, 2022
-6.62 USD
Jan 1, 2023
-1.02 USD
Jan 1, 2024
-2.42 USD
Jan 1, 2025
-8,544.19 USD
The Aditxt DSCR history
YEARDSCRYoY
-8,544.19+352,654.58%
-2.42+137.54%
-1.02-84.60%
-6.62+40.33%
-4.72+20.03%
-3.93+40.19%
-2.80+18.77%
-2.36—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Aditxt Stock analysis

What does Aditxt do? ADiTx Therapeutics, Inc. develops nucleic acid-based technologies for organ transplant tolerance and immune system health. The company's Apoptotic DNA Immunotherapy (ADi) reprograms the immune system to induce tolerance, while Aditxt Immune Monitor (AiM) provides personalized immune profiles. Both technologies are in preclinical development, with the firm focusing on minimizing transplant rejection and addressing autoimmune diseases and allergies. The company is headquartered in Mountain View, California and employs 2 full-time staff. ADiTx Therapeutics, Inc. generates revenue through the development and potential future commercialization of its immune reprogramming and monitoring technologies. The company is a preclinical stage life sciences entity targeting medical applications in organ transplantation and immune-related conditions. Its core products, ADi and AiM, are designed to address unmet medical needs in immune system management. The firm's focus on immune reprogramming and monitoring positions it for potential partnerships with healthcare providers and biopharmaceutical companies in the future. Aditxt is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Aditxt stock

Debt Service Coverage Ratio (DSCR) of Aditxt is -8,544.19 in 2025.

Debt Service Coverage Ratio (DSCR) of Aditxt changed from -2.42 to -8,544.19, representing a 352,654.58% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Service Coverage Ratio (DSCR) Aditxt since 2006 – with annual values, charts, and detailed analysis.

The DSCR measures a company's ability to service its debt obligations from operating income. A ratio above 1.0 indicates sufficient income to cover debt payments.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt Service Coverage Ratio (DSCR)'s Aditxt with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Aditxt

All Key Metrics — Aditxt